Medical cannabis comparative analysis database

The medical cannabis comparative analysis database allows you to easily compare different aspects of medical cannabis programmes from across the globe. It allows you to sort through various features of medical cannabis programmes to identify similar programmes and then see how the similar programme developed in a similar regulatory environment.

The jurisdictions covered were selected based on their relative size, maturity, and unique aspects of their regulations. CannIntelligence will add jurisdictions to the database over time.

I'm already a subscriber

Anthony Traurig

Senior advisor
Anthony is senior advisor to CannIntelligence, where he provides regulatory guidance on issues within the global cannabis sector. Having worked several years as a legal analyst at CannIntelligence, he continues to work on consultancy projects and contribute to regulatory products for the platform. Anthony has a BA in political science from North Carolina State University and a Juris Doctor from Charleston School of Law (South Carolina), and practised law for several years in the United States as a litigator.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization